Medicines Control Authority of Zimbabwe

03/02/2026

📢NOTICE TO ALL APPROVED PHARMACEUTICAL WHOLESALE DEALERS

The Medicines Control Authority of Zimbabwe (MCAZ) hereby notifies all importers that it will conduct field screening of imported medicines at ports of entry. This initiative supports the MCAZ's mandate to ensure the safety, quality, and efficacy of all medicines in Zimbabwe. All screening activities will be at the Authority's expense.

MCAZ officers will be stationed at Robert Gabriel Mugabe International Airport to sample and screen imported pharmaceutical products using field detection and rapid screening technologies. Importers that use other designated ports of entry will be required to bring samples for screening to MCAZ offices as part of their physical examination process. These measures are designed to identify substandard and falsified medicines before they enter the national supply chain.

🚨 Details:https://portal.mcaz.co.zw/wp-content/uploads/2026/01/Circular-03-of-2026-Notification-of-Post-Market-Survellance-PMS-Screening-of-Imported-Medicines-at-Ports-of-Entry.pdf

28/01/2026

⚠️The MCAZ wishes to advise healthcare professionals, patients, and the general public of the detection of unauthorised Goserelin Acetate (Zoladex) 10.8mg injections circulating on the market through unapproved distribution channels.

Healthcare providers and pharmacies have been instructed to quarantine and surrender the unauthorised medicine to MCAZ for disposal, while members of the public who may have obtained it are urged to return it to the seller.

MCAZ continues to monitor the pharmaceutical market and advises the public to only use medicines that are registered and approved by the Authority.

Details:https://portal.mcaz.co.zw/wp-content/uploads/2026/01/MCAZ-Circular-4-of-2026-Unauthorised-Zoladex-for-publishing-2-1.pdf

28/01/2026

📢 Announcement

MCAZ wishes to remind all medicinal cannabis licence holders of their obligation to submit annual returns in line with Section 16 of the Dangerous Drugs (Production of Cannabis for Medicinal and Scientific Use) Regulations, Statutory Instrument 62 of 2018. Compliance with regulatory requirements is mandatory.
For more details:https://portal.mcaz.co.zw/.../MCAZ-Circular-02-of-2026.pdf

27/01/2026

📢 Public Announcement

RENEWAL OF LICENCES FOR THE PRODUCTION OF CANNABIS FOR MEDICINAL AND SCIENTIFIC USE.

The Medicines Control Authority of Zimbabwe would like to draw the attention of all producers of cannabis for medicinal and scientific use with licences issued in 2021 that the five (5) year validity period is lapsing this year. This applies to licence numbers: 001/2021 to 010/2021. In order to avoid inconveniences, all licences should be renewed before expiry.

For More Details:https://portal.mcaz.co.zw/wp-content/uploads/2026/01/MCAZ-Circular-01-of-2026.pdf

12/01/2026

📌Following the publication of CIRCULAR 35 of 2025, https://portal.mcaz.co.zw/wp-content/uploads/2025/12/CIRCULAR-35-of-2025-PUBLICATION-IMPLEMENTATION-OF-THE-NATIONAL-MEDICINES-AVAILABILITY.pdf ) the MCAZ is inviting registered pharmacies that wish to participate in the pilot phase of MAT-TP to register with the Authority.

Registration can be done on this link: https://forms.gle/y3sEPaECYug4njJQ9

📢 MCAZ has launched the National Medicines Availability & Price Transparency Platform (MAP-TP), marking a significant milestone in the digital transformation of Zimbabwe’s public health and regulatory systems. The platform, also called Medicine Price Lookup, has been introduced to enhance transparency, strengthen patient protection, and provide citizens with accurate, non-promotional information on medicine availability and pricing nationwide.

The Authority is inviting licensed pharmacies to submit Expressions of Interest to join the pilot phase within 14 days. The pilot will allow MCAZ to test system functionality, validate data integrity, and ensure readiness ahead of national implementation.

🔗 Access the platform: lookup.mcaz.graccasoft.com

🚨 Details:https://portal.mcaz.co.zw/wp-content/uploads/2025/12/CIRCULAR-35-of-2025-PUBLICATION-IMPLEMENTATION-OF-THE-NATIONAL-MEDICINES-AVAILABILITY.pdf

05/01/2026

The Authority has resumed operations following the festive season break, with compliments of the new season to its stakeholders. All core regulatory services are now fully operational, with the MCAZ team ready to serve you.

MCAZ remains committed to protecting the public’s right to safe, effective, and quality medicines and medical devices.

02/01/2026

Compliments of the New Season

29/12/2025

🚨NOTICE

24/12/2025

MCAZ wishes all its stakeholders a Merry Christmas and a Prosperous 2026

22/12/2025

The MCAZ joins His Excellency President Dr. E D Mnangagwa and the nation at large in celebrating Unity Day

16/12/2025

16/12/2025

The Medicines Control Authority of Zimbabwe (MCAZ) successfully convened a Consultative Stakeholders Meeting on the Production and Distribution of Locally Produced Medical Devices Regulations.

Stakeholders were allowed to review the draft regulations, share insights, and provide input aimed at strengthening the regulation of locally produced medical devices while supporting innovation and safeguarding public health.

MCAZ extends its appreciation to all stakeholders who participated and contributed to the consultative process.